(Q34596369)

English

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.

scientific article

Statements

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer. (English)
Henry Q Xiong
Gauri R Varadhachary
Joan C Blais
Kenneth R Hess
James L Abbruzzese
Robert A Wolff
1 October 2008
2046-2052

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit